Depressive Disorder  >>  lisdexamfetamine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lisdexamfetamine / Generic mfg.
NCT01093963: Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Terminated
3
25
US
Lisdexamfetamine, Placebo
Lindner Center of HOPE, Shire, University of Cincinnati
Bipolar Depression
02/14
02/14
NCT01131559: Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Terminated
3
50
US
Lisdexamfetamine, Vyvanse, Placebo control, Sugar pill, fake pill with no active medication
Lindner Center of HOPE, Shire, University of Cincinnati
Bipolar, Depression
02/14
02/14

Download Options